Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Neutron Therapeutics Finland Oy
OY
Active
Y-tunnus 2740732-9
Kanavaranta 9, 00160
Helsinki
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2016
— employees
Watchlist
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Neutron Therapeutics Finland Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
TH
Theodore Harrison Smick
Deputy Member
Deputy Member
2024
HT
Heidi-Maria Tuulia Meriluoto
Person with significant control
Person with significant control
2023
NM
Noah Meade Smick
Chief Executive Officer
Chief Executive Officer
2020
Former (6)
EE
Elizabeth Emily Reczek
Deputy Member
Deputy Member
2022 – 2024
IK
Ilkka Kristian Kujala
Audit
Audit
2022 – 2023
TM
Toni Markus Piponius
Person with significant control
Person with significant control
2022 – 2023
JP
Jyri Pekka Heikkinen
Audit
Audit
2016 – 2019
JM
Jason Michael Walsh
Deputy Member
Deputy Member
2020 – 2022
ET
Erkki-Paavo Tenhunen
Chief Executive Officer
Chief Executive Officer
2016 – 2019
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
ML
Mikko Lauri Sampsa Mannerkoski
Board of Directors
2018 – 2019
SI
Stewart Ian Buckley
Chairperson
2018 – 2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Neutron Therapeutics Finland Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network